文献速递瓣膜外科主动脉外科

经导管主动脉瓣置换失败后主动脉瓣置换与根部置换的比较

Aortic valve versus root surgery after failed transcatheter aortic valve replacement.
PubMed 文献 · J Thorac Cardiovasc Surg · 2022-03-26

该回顾性注册研究比较经导管主动脉瓣置换(TAVR)外科移除时行主动脉瓣置换(168例)与根部置换(28例)的结局。两组临床特征不同,但短期死亡率和并发症无差异。作者认为需进一步研究识别TAVR移除时需根部置换的风险患者。

要点

  • TAVR移除时根部置换组较主动脉瓣置换组redo TAVR不利解剖更多(52.6% vs 26.4%,P=.032)。
  • 根部置换组较主动脉瓣置换组紧急/急诊手术更少(32.1% vs 58.3%,P=.013)。
  • 两组院内、30天和1年死亡率和卒中率无差异。

核心结论

  • 在EXPLANT-TAVR注册研究中,主动脉瓣置换与根部置换组临床特征不同,但短期死亡率和并发症无差异。
  • 需进一步研究以识别TAVR移除时需根部置换的风险患者。

研究设计与样本

  • 回顾性分析EXPLANT-TAVR国际注册研究2009年11月至2020年9月接受TAVR移除的患者数据,按主动脉瓣置换与根部置换分组。
  • 排除与初始TAVR同次住院期间进行的移除和涉及其他瓣膜的同期手术,比较168例主动脉瓣置换与28例根部置换,报告30天和1年结局。

主要发现

  • 196例患者(平均年龄73.5±9.9岁)在TAVR移除时接受初次主动脉瓣干预,从TAVR至外科移除的中位时间为11.2个月(四分位距4.4-32.9个月)。
  • 根部置换组较主动脉瓣置换组redo TAVR不利解剖更多(52.6% vs 26.4%;P=.032),紧急/急诊手术更少(32.1% vs 58.3%;P=.013),从初始TAVR至移除的中位间隔更长(17.6 vs 9.9个月;P=.047),同期升主动脉置换更多(58.8% vs 14.0%;P<.001)。
  • TAVR移除后中位随访6.9个月(四分位距1.4-21.6个月),随访完整率97.4%,随访总生存率81.2%,两组无差异(log rank P=.54)。
  • 两组院内、30天和1年死亡率和卒中率无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需进一步研究以识别TAVR移除时需根部置换的风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We sought to determine outcomes of aortic valve replacement (AVR) versus root replacement after transcatheter AVR (TAVR) explantation because they remain unknown. METHODS: From November 2009 to September 2020, data from the EXPLANT-TAVR International Registry of patients who underwent TAVR explant were retrospectively reviewed, divided by AVR versus root replacement. After excluding explants performed during the same admission as the initial TAVR and concomitant procedures involving the other valves, 168 AVR cases were compared with 28 root replacements, and outcomes were reported at 30 days and 1 year. RESULTS: Among 196 patients (mean age, 73.5 ± 9.9 years) who had primary aortic valve intervention at TAVR explant, the median time from TAVR to surgical explant was 11.2 months (interquartile range, 4.4-32.9 months). Indications for explant were similar between the 2 groups. Compared with AVR, patients requiring root replacement had fewer comorbidities but more unfavorable anatomy for redo TAVR (52.6% vs 26.4%; P = .032), fewer urgent/emergency cases (32.1% vs 58.3%; P = .013), longer median interval from index TAVR to TAVR explant (17.6 vs 9.9 months; P = .047), and more concomitant ascending aortic replacement (58.8% vs 14.0%; P < .001). Median follow-up was 6.9 months (interquartile range, 1.4-21.6 months) after TAVR explant and 97.4% complete. Overall survival at follow-up was 81.2% with no differences between groups (log rank P = .54). In-hospital, 30-day, and 1-year mortality rates and stroke rates were not different between the 2 groups. CONCLUSIONS: In the EXPLANT-TAVR Registry, AVR and root replacement groups had different clinical characteristics, but no differences in short-term mortality and morbidities. Further investigations are necessary to identify patients at risk of root replacement in TAVR explant.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Vitanova K, Zaid S, Tang GHL, et al. Aortic valve versus root surgery after failed transcatheter aortic valve replacement. J Thorac Cardiovasc Surg. 2022. PMID: 35525801. doi:10.1016/j.jtcvs.2021.12.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。